# Enhanced Antimalarial Efficacy of Annona muricata Leaf Extract Combined With Artesunate, Chloroquine, and Pyrimethamine in Plasmodium berghei–Infected ICR Mice

**Authors:** Orawan Sarakul, Rachasak Boonhok, Voravuth Somsak

PMC · DOI: 10.1155/adpp/8736555 · Advances in Pharmacological and Pharmaceutical Sciences · 2025-08-07

## TL;DR

This study shows that combining a plant extract from Annona muricata with certain antimalarial drugs improves treatment effectiveness in mice infected with malaria.

## Contribution

The novel contribution is demonstrating synergistic antimalarial effects of Annona muricata extract with artesunate and pyrimethamine.

## Key findings

- AME alone showed significant antimalarial activity at higher doses.
- AME combined with artesunate and pyrimethamine achieved over 90% inhibition of parasitemia.
- Combination with chloroquine did not show synergistic effects.

## Abstract

Malaria continues to be a significant global health challenge, particularly in tropical and subtropical regions, due to its high morbidity and mortality rates. The development of resistance to conventional antimalarial drugs underscores the urgent need for novel therapeutic approaches. Artemisinin-based combination therapies (ACTs) are effective but face emerging resistance issues. This study explores the antimalarial efficacy of Annona muricata leaf extract (AME) when combined with artesunate (ART), chloroquine (CQ), and pyrimethamine (PYR) in Plasmodium berghei–infected ICR mice. Fresh A. muricata leaves were processed to produce a crude ethanolic extract. ART, CQ, and PYR were prepared and administered to ICR mice infected with P. berghei ANKA. The study evaluated the parasitemia levels and survival rates, comparing combination treatments to monotherapies. The combination treatments were analyzed for synergistic interactions. Results indicated that AME alone exhibited significant antimalarial activity, especially at higher doses. The combination of AME with ART and PYR demonstrated significant synergistic effects, achieving over 90% inhibition of parasitemia and significantly prolonging mean survival times up to 30 days. However, the combination of AME with CQ did not show synergistic effects. These findings suggest that AME, particularly in combination with ART or PYR, could enhance antimalarial efficacy and offer a promising alternative to current treatments, potentially mitigating drug resistance issues. Further research is warranted to validate these combinations and explore their mechanisms of action.

## Linked entities

- **Chemicals:** artesunate (PubChem CID 6917864), chloroquine (PubChem CID 2719), pyrimethamine (PubChem CID 4993)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium berghei (taxon 5821), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** Malaria (MESH:D008288), parasitemia (MESH:D018512)
- **Chemicals:** PYR (MESH:D011739), AME (-), CQ (MESH:D002738), ART (MESH:D000077332), Artemisinin (MESH:C031327)
- **Species:** Plasmodium berghei ANKA (strain) [taxon 5823], Mus musculus (house mouse, species) [taxon 10090], Plasmodium berghei (species) [taxon 5821], Acropora muricata (species) [taxon 159855]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12353001/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12353001/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12353001/full.md

---
Source: https://tomesphere.com/paper/PMC12353001